Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,817 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial.
Asano T, Tanigaki T, Hoshino M, Yasunaga M, Nonaka H, Emori H, Katagiri Y, Miyazaki Y, Sotomi Y, Kogame N, Kuramitsu S, Saito A, Miyata K, Takaoka Y, Kanie T, Yamasaki M, Yoshino K, Wakabayashi N, Ouchi K, Kodama H, Shiina Y, Tamaki R, Nishihata Y, Masuda K, Suzuki T, Reiber JHC, Okamura T, Higuchi Y, Kakuta T, Misumi H, Abe K, Komiyama N, Tanabe K, Matsuo H, Qfr Investigators OBOTD. Asano T, et al. Among authors: miyata k. EuroIntervention. 2024 May 10;20(9):561-570. doi: 10.4244/EIJ-D-23-00674. EuroIntervention. 2024. PMID: 38726719 Free article. Clinical Trial.
[Improvement of tissue fibrosis in TAFRO syndrome by prednisolone monotherapy].
Kashiwagi T, Kashiwagi Y, Suzuki T, Shingu M, Kashiwagi S, Hirata T, Hori J, Miyata K, Takechi M, Kishi M, Ohnishi T, Katayama Y, Iwai M, Matsui T. Kashiwagi T, et al. Among authors: miyata k. Rinsho Ketsueki. 2024;65(4):237-242. doi: 10.11406/rinketsu.65.237. Rinsho Ketsueki. 2024. PMID: 38684433 Japanese.
Sociodemographic disparities in sodium-glucose cotransporter-2 inhibitor use among US kidney transplant recipients: An observational study of real-world pharmacy records.
Lentine KL, Miyata KN, Lam NN, Joseph C, McAdams-DeMarco M, Bae S, Chen Y, Caliskan Y, Sarabu N, Dhindsa S, Xiao H, Segev DL, Axelrod DA, Schnitzler MA. Lentine KL, et al. Among authors: miyata kn. Clin Transplant. 2024 Apr;38(4):e15257. doi: 10.1111/ctr.15257. Clin Transplant. 2024. PMID: 38563475
Protocol of a phase II study investigating the efficacy and safety of trifluridine/tipiracil plus ramucirumab as a third-line or later treatment for advanced gastric cancer.
Nakanishi K, Tanaka C, Kanda M, Miyata K, Machida N, Sakai M, Kobayashi D, Teramoto H, Ishiyama A, Sato B, Oshima T, Kajikawa M, Matsushita H, Ishigure K, Yamashita K, Fujitake S, Sueoka S, Asada T, Shimizu D, Sugita S, Kuwatsuka Y, Maeda O, Furune S, Murotani K, Ando Y, Ebata T, Kodera Y. Nakanishi K, et al. Among authors: miyata k. Nagoya J Med Sci. 2024 Feb;86(1):43-51. doi: 10.18999/nagjms.86.1.43. Nagoya J Med Sci. 2024. PMID: 38505718 Free PMC article.
Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacy.
Horiguchi H, Kadomatsu T, Yamashita T, Yumoto S, Horino T, Sato M, Terada K, Miyata K, Ichigozaki Y, Kimura T, Fukushima S, Moroishi T, Oike Y. Horiguchi H, et al. Among authors: miyata k. Cancer Gene Ther. 2024 Mar 11. doi: 10.1038/s41417-024-00757-9. Online ahead of print. Cancer Gene Ther. 2024. PMID: 38467764
1,817 results